1999
DOI: 10.1002/(sici)1522-2586(199907)10:1<15::aid-jmri3>3.0.co;2-x
|View full text |Cite
|
Sign up to set email alerts
|

A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0
1

Year Published

2000
2000
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 53 publications
(22 citation statements)
references
References 27 publications
0
20
0
1
Order By: Relevance
“…Although MnCl 2 is used as an MRI contrast agent for the gastrointestinal tract in human, 25 systemic administration of MnCl 2 at the concentration used in this study is restrained in human applications because of its toxicity. 26 Therefore, we conducted MEMRI of the pleural tumors using MnDPDP, an Mn-releasing contrast agent used for human liver imaging.…”
Section: Discussionmentioning
confidence: 99%
“…Although MnCl 2 is used as an MRI contrast agent for the gastrointestinal tract in human, 25 systemic administration of MnCl 2 at the concentration used in this study is restrained in human applications because of its toxicity. 26 Therefore, we conducted MEMRI of the pleural tumors using MnDPDP, an Mn-releasing contrast agent used for human liver imaging.…”
Section: Discussionmentioning
confidence: 99%
“…For T 1 -weighted images, most authors use gradient echo sequences in two-and three-dimensional acquisition modes with or without fat saturation prepulses (Figure 1), whereas for T 2 -weighted images, TSE and HASTE sequences are commonly employed. 2,19,20 More recently, the true FISP sequence has been successfully applied in bowel imaging, 12 providing high-resolution images of the bowel wall ( Figure 2) and additional information from the mesentery. Fat-suppressed TSE or STIR sequences have been also applied to assess activity in Crohn's disease.…”
Section: Pulse Sequencesmentioning
confidence: 99%
“…While recent advances have been made in the search for water soluble manganese-based small molecule contrast agents,6-12 only two Mn 2+ -containing contrast agents have been approved for clinical use. [Mn(dipyridoxyldiphosphate)] 4− is the paramagnetic component of Teslascan®, a liver imaging agent13,14 while LumenHance®, which contains MnCl 2 , is employed in GI imaging 15…”
Section: Introductionmentioning
confidence: 99%